Quick Answer
10x Genomics, Inc. reported Total Revenue of $642.82 million for fiscal year 2025.
10x Genomics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $642.82M | +5.2% |
| 2024 | $610.78M | -1.3% |
| 2023 | $618.73M | +19.8% |
| 2022 | $516.41M | +5.3% |
| 2021 | $490.49M | +64.1% |
| 2020 | $298.85M | +21.5% |
| 2019 | $245.89M | +68.1% |
| 2018 | $146.31M | +105.8% |
| 2017 | $71.08M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $149.00M | -1.7% | -13.8% |
| June 30, 2025 | $172.91M | +12.9% | +11.6% |
| March 31, 2025 | $154.88M | +9.8% | +2.1% |
| September 30, 2024 | $151.65M | -1.3% | -0.9% |
| June 30, 2024 | $153.10M | +4.3% | +8.6% |
| March 31, 2024 | $141.01M | +5.0% | -8.2% |
| September 30, 2023 | $153.64M | +17.2% | +4.6% |
| June 30, 2023 | $146.82M | +28.1% | +9.3% |
- 10x Genomics, Inc. showed an increase of +5.2% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2025 period, 10x Genomics, Inc.’s total revenue has grown by 804.3% (from $71.08 million to $642.82 million).
- The most recent figure is from 10x Genomics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: